US2019209993A1PendingUtilityA1

Conversion of nitrogen dioxide (no2) to nitric oxide (no)

63
Assignee: Vero Biotech LLCPriority: Sep 22, 2008Filed: Oct 1, 2018Published: Jul 11, 2019
Est. expirySep 22, 2028(~2.2 yrs left)· nominal 20-yr term from priority
A61M 2202/0078A61M 16/10C01B 21/24A61M 2202/0275A61M 2205/12A61M 2016/1025A61K 33/00A62B 7/08A61M 2205/07B01J 12/007A61M 2202/0007A61M 16/122Y02A50/20
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A nitric oxide delivery system, which includes a gas bottle having nitrogen dioxide in air, converts nitrogen dioxide to nitric oxide and employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid. A nitric oxide delivery system may be used to generate therapeutic gas including nitric oxide for use in delivering the therapeutic gas to a mammal.

Claims

exact text as granted — not AI-modified
1 . A method of delivering the therapeutic gas to a mammal comprising:
 diffusing gaseous nitrogen dioxide into an air flow wherein the air flow is configured to be between 5 to 60 liters per minute;   receiving the air flow at an inlet of a receptacle, the receptacle including the inlet, an outlet, and a surface-active material coated with an aqueous solution of an antioxidant, wherein the air flow is fluidly communicated to the outlet through the surface-active material to convert the gaseous nitrogen dioxide to nitric oxide at ambient temperature prior to delivery to the mammal.   
     
     
         2 .- 11 . (canceled) 
     
     
         12 . The method of  claim 1 , wherein the air flow is at 5 liters per minute. 
     
     
         13 . The method of claim  2 , wherein the receptacle has a pressure drop of between 0.001 and 0.01 psi. 
     
     
         14 . The method of  claim 1 , wherein the air flow is at 60 liters per minute or lower. 
     
     
         15 . The method of claim  4 , wherein the receptacle has a pressure drop of between 0.001 and 0.05 psi. 
     
     
         16 . The method of  claim 1 , wherein the receptacle comprises a cartridge. 
     
     
         17 . The method of  claim 1 , wherein the surface-active material is saturated with the aqueous solution of the antioxidant. 
     
     
         18 . The method of  claim 1 , wherein the surface-active material comprises a substrate that retains water. 
     
     
         19 . The method of  claim 1 , wherein the surface-active material comprises a silica gel. 
     
     
         20 . The method of  claim 1 , wherein the antioxidant comprises ascorbic acid. 
     
     
         21 . The method of  claim 1 , wherein the antioxidant comprises alpha tocopherol or gamma tocopherol.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.